4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:主营:癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > Other_reagents > Adipogen/Y-27632 . dihydrochloride/AG-CR1-3564-M005/5 mg
商品详细Adipogen/Y-27632 . dihydrochloride/AG-CR1-3564-M005/5 mg
Adipogen/Y-27632 . dihydrochloride/AG-CR1-3564-M005/5 mg
Adipogen/Y-27632 . dihydrochloride/AG-CR1-3564-M005/5 mg
商品编号: AG-CR1-3564-M005
品牌: Adipogen Inc
市场价: ¥1600.00
美元价: 960.00
产地: 美国(厂家直采)
公司:
产品分类: 其他试剂
公司分类: Other_reagents
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍
MoreInformation
ProductDetails
Synonyms(R)-(+)-trans-4-(1-Aminoethyl)-N-(4-pyridyl)cyclohexanecarboxamidedihydrochloride
ProductTypeChemical
Properties
FormulaC14H21N3O.2HCl
MW247.3.72.9
CAS129830-38-2|146986-50-7(freebase)
PurityChemicals≥98%(HPLC)
Containsapprox.1.4%water.
AppearanceWhitetopaleyellowsolid.
SolubilitySolubleinwater,DMSO(25mg/ml)ormethanol(25mg/ml).
IdentityDeterminedby1H-NMR.
InChiKeyIYOZTVGMEWJPKR-VOMCLLRMSA-N
ShippingandHandling
ShippingAMBIENT
ShortTermStorage+4°C
LongTermStorage-20°C
HandlingAdviceAfterreconstitution,preparealiquotsandstoreat-20°C.
Keepunderinertgas.
Protectfromlight.
Use/StABIlityStableforatleast2yearsafterreceiptwhenstoredat-20°C.
Stocksolutionsarestableforatleast3monthswhenstoredat-20°C.
Documents
MSDSDownloadPDF
ProductSpecificationSheet
DatasheetDownloadPDF
  • Potent,cellpermeable,selectiveandATP-competitiveRho-associatedproteinkinasesinhibitor,includingp160ROCK,ROCK-IIandPRK2inhibitor[1,3-5].
  • Tumorcellinvasionandmetastasissuppressor[2,15].
  • Smoothmusclerelaxant[1,6].
  • Decreasesliverfibrosisbyhepaticstellatecellgrowthinhibition[7,8].
  • Antinociceptive[9].
  • Blocksgenerationofinflammatorycytokines[10].
  • Stemcellresearchmodulator[11-14,16].
  • Preventsapoptosisandenhancesthesurvivalandcloningefficiencyofdissociatedhumanembryonicstem(hES)cellswithoutaffectingtheirpluripotency.IncreasessurvivalrateofhEScellsundergoingcryopreservation[11-14,16].
ProductReferences
  1. CalciumsensitizationofsmoothmusclemediatedbyaRho-associatedproteinkinaseinhypertension:M.Uehata,etal.;Nature389,990(1997)
  2. AnessentialpartforRho-associatedkinaseinthetranscellularinvasionoftumorcells:K.Itoh,etal.;Nat.Med.5,221(1999)
  3. UseandpropertiesofROCK-specificinhibitorY-27632:S.Narumiya,etal.;Meth.Enzymol.325,273(2000)
  4. Specificityandmechanismofactionofsomecommonlyusedproteinkinaseinhibitors:S.P.Davies,etal.;Biochem.J.351,95(2000)
  5. PharmacologicalpropertiesofY-27632,aspecificinhibitorofrho-associatedkinases:T.Ishizaki,etal.;Mol.Pharmacol.57,976(2000)
  6. Y-27632potentiatesrelaxanteffectsofbeta2-adrenoceptoragoNISTsinbovinetrachealsmoothmuscle:T.Nakahara,etal.;Eur.J.Pharmacol.389,103(2000)
  7. Ap160ROCK-specificinhibitor,Y-27632,attenuatesrathepaticstellatecellgrowth:H.Iwamoto,etal.;J.Hepatol.32,762(2000)
  8. InhibitionofintrahepaticmetastasisofhumanhepatocellularcarcinomabyRho-associatedproteinkinaseinhibitorY-27632:M.Takamura,etal.;Hepatology33,577(2001)
  9. Rho-kinaseinhibitor,Y-27632,hasanantinociceptiveeffectinmice:K.Buyukafsar,etal.;Eur.J.Pharmacol.541,49(2006)
  10. NovelRhokinaseinhibitorswithanti-inflammatoryandvasodilatoryactivities:C.Doe,etal.;JPET320,89(2007)
  11. AROCKinhibitorpermitssurvivalofdissociatedhumanembryonicstemcells:K.Watanabe,etal.;Nat.Biotechnol.25,681(2007)
  12. TheROCKinhibitorY-27632enhancesthesurvivalrateofhumanembryonicstemcellsfollowingcryopreservation:X.Li,etal.;StemCellsDev.17,1079(2008)
  13. EffectofRho-associatedkinase(ROCK)inhibitorY-27632onthepost-thawviabilityofcryopreservedhumanbonemarrow-derivedmesenchymalstemcells:B.C.Heng;TissueCell 41,376(2009)
  14. EffectofROCKinhibitorY-27632onnormalandvarianthumanembryonicstemcells(hESCs)invitro:itsbenefitsinhESCexpansion:K.Gauthaman,etal.;StemCellRev.6,86(2010)
  15. PharmacologicalinhibitionofRho-kinasesignalingwithY-27632blocksmelanomatumorgrowth:A.Routhier,etal.;Oncol.Rep.23,861(2010)
  16. TheROCKinhibitorY-27632improvesrecoveryofhumanembryonicstemcellsafterfluorescence-activatedcellsortingwithmultiplecellsurfaceMarkers:N.Emre,etal.;PLoSOne5,e12148(2010)
品牌介绍
Adipogen公司由三个子公司组成,分别是Adipogen,Inc.(韩国),AdipogenSA(瑞士)和 AdipogenCorporation(美国圣地亚哥)。总部设在美国,运营总部在瑞士利斯塔尔。Adipogen公司专门从事生命科学研究试剂的开发,如癌症、免疫、炎症、代谢疾病(糖尿病、肥胖)、干细胞和神经退行性疾病等领域。其重点关注开发创新优质的ELISA试剂盒。另外,也可提供抗体和蛋白产品,Adipogen拥有自己的化学实验室,致力于开发创新型小分子化合物。